Literature DB >> 18992966

Lack of classic histology should not prevent diagnosis of necrolytic acral erythema.

Danette Bentley1, Aleodor Andea, Aton Holzer, Boni Elewski.   

Abstract

We describe a patient who was referred for management of psoriasis unresponsive to treatment. Given the predominantly acral distribution of the patient's rash and his known diagnosis of hepatitis C, we considered the diagnosis of necrolytic acral erythema (NAE) and empirically began treatment with oral zinc sulfate. At follow-up 3 weeks later, the patient had exceptional improvement in his cutaneous disease, supporting our diagnosis of NAE. NAE is a recently described entity, and limited information is known regarding its etiology and pathogenesis; however, previous reports have been fairly consistent regarding the clinical and histopathologic presentation. We describe a patient without the classic histologic or clinical findings of previously described cases of NAE. We believe that it is important to keep the diagnosis of NAE in one's differential for a predominantly acrally distributed rash. Furthermore, we recommend additional work-up, including hepatitis C status and zinc levels, as well as possible treatment with oral zinc sulfate in patients with a potential diagnosis of NAE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992966      PMCID: PMC2708073          DOI: 10.1016/j.jaad.2008.08.046

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

1.  Zinc deficiency associated with necrolytic acral erythema.

Authors:  David James Najarian; Ilyse Lefkowitz; Erika Balfour; Amy S Pappert; Babar K Rao
Journal:  J Am Acad Dermatol       Date:  2006-11       Impact factor: 11.527

2.  Necrolytic acral erythema: a patient from the United States successfully treated with oral zinc.

Authors:  Mahmoud A Abdallah; Cheryl Hull; Thomas D Horn
Journal:  Arch Dermatol       Date:  2005-01

3.  Necrolytic acral erythema in Egyptian patients with hepatitis C virus infection.

Authors:  Tarek M El-Ghandour; Mohammad A Sakr; Hatem El-Sebai; Tarek F El-Gammal; Manal H El-Sayed
Journal:  J Gastroenterol Hepatol       Date:  2006-07       Impact factor: 4.029

4.  A trial of oral zinc supplementation in psoriasis.

Authors:  N P Burrows; A J Turnbull; N A Punchard; R P Thompson; R R Jones
Journal:  Cutis       Date:  1994-08

5.  Necrolytic acral erythema: a variant of necrolytic migratory erythema or a distinct entity?

Authors:  Ahmad Abdelgawad Nofal; Eman Nofal; Enayat Attwa; Ola El-Assar; Magda Assaf
Journal:  Int J Dermatol       Date:  2005-11       Impact factor: 2.736

6.  Necrolytic acral erythema: a cutaneous marker of viral hepatitis C.

Authors:  M el Darouti; M Abu el Ela
Journal:  Int J Dermatol       Date:  1996-04       Impact factor: 2.736

7.  Effect of zinc therapy on neutrophil chemotaxis in psoriasis.

Authors:  V Leibovici; M Statter; L Weinrauch; E Tzfoni; Y Matzner
Journal:  Isr J Med Sci       Date:  1990-06

8.  Necrolytic acral erythema: a cutaneous sign of hepatitis C virus infection.

Authors:  Mahmoud A Abdallah; Mohamed Y Ghozzi; Hoda A Monib; Aisha M Hafez; Kim M Hiatt; Bruce R Smoller; Thomas D Horn
Journal:  J Am Acad Dermatol       Date:  2005-08       Impact factor: 11.527

Review 9.  Necrolytic acral erythema: response to combination therapy with interferon and ribavirin.

Authors:  Chad M Hivnor; Albert C Yan; Jacqueline M Junkins-Hopkins; Paul J Honig
Journal:  J Am Acad Dermatol       Date:  2004-05       Impact factor: 11.527

10.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

View more
  5 in total

1.  Seronegative necrolytic acral erythema: a distinct clinical subset?

Authors:  S Panda; K Lahiri
Journal:  Indian J Dermatol       Date:  2010 Jul-Sep       Impact factor: 1.494

2.  Diagnosing necrolytic acral erythema: does anything go?

Authors:  Jayanta Kumar Das
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

3.  Authors' reply.

Authors:  Saumya Panda; Koushik Lahiri
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

Review 4.  Necrolytic acral erythema as a cutaneous marker of hepatitis C: report of two cases and review.

Authors:  James H Tabibian; Meg R Gerstenblith; Ryan J Tedford; Jacqueline M Junkins-Hopkins; Rachel Abuav
Journal:  Dig Dis Sci       Date:  2010-05-26       Impact factor: 3.487

5.  Necrolytic acral erythema: a rare skin disease associated with hepatitis C virus infection.

Authors:  Luciane Francisca Fernandes Botelho; Milvia Maria Simões E Silva Enokihara; Mauro Yoshiaki Enokihara
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.